More than 100 medicines now appear on the government’s drug shortage list. Those most often in short supply include anesthetics and oncological drugs, according to the Food & Drug Administration....
EEOC issues final rules on workplace wellness programs
By
May 18, 2016
Employers may offer employees and their spouses incentives for joining workplace wellness programs up to 30% of their individual “self-only” health coverage, the Equal Employment Opportunity...
Study: Elderly nursing home residents at lower risk for fractures
By
Haymarket Media
Jun 07, 2006
Elderly female nursing home residents have fewer skeletal fractures than women who live at home. They are also older when those fractures occur, according to the results of a new study.
Study: Gene therapy may reduce effects of Alzheimer’s
By
Haymarket Media
Apr 26, 2005
A small study using gene therapy to treat Alzheimer’s patients proved to slow the progression of the disease, according to initial reviews of the evidence.
David Grabowski: Getting Geeky with LTC
By
Marty Stempniak
Jun 08, 2018
David Grabowski Professor in Health Care Policy Harvard Medical School David Grabowski freely admits that he’s a “long-term care geek.” The professor of healthcare policy at Harvard Medical...
CMS: Part D drug premiums to increase
By
Haymarket Media
Oct 01, 2007
The average monthly premium for Medicare Part D prescription drug coverage will increase slightly over the previous two years, the Centers for Medicare & Medicaid Services said last week.
FDA approves only 17 new drugs last year
By
Haymarket Media
Jan 05, 2007
The Food and Drug Administration last year approved only 17 new prescription drugs, the lowest number of new drug approvals in a decade, according to a new study.
Another double-digit rise in healthcare costs forecast
By
Haymarket Media
Nov 03, 2004
Employers will see their medical plan costs rise an average of 13.5%, according to a new analysis by Aon Corp.
CMS to recover $4 billion in overpayments for Part D drugs
By
Haymarket Media
Oct 15, 2007
The Centers for Medicare & Medicaid Services said that because actual drug costs were lower than expected, Part D drug plan sponsors will need to return $4 billion to the agency.
Discovery could speed sepsis treatment
By
Kimberly Marselas
Dec 01, 2014
Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by a discovery at the University of British Columbia.